470 related articles for article (PubMed ID: 30378252)
1. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
2. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
3. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis.
Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L
Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
5. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
[TBL] [Abstract][Full Text] [Related]
6. Essential role of IL-17 in acute exacerbation of pulmonary fibrosis induced by non-typeable
Chen S; Zhang X; Yang C; Wang S; Shen H
Theranostics; 2022; 12(11):5125-5137. PubMed ID: 35836804
[No Abstract] [Full Text] [Related]
7. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
[TBL] [Abstract][Full Text] [Related]
8. [IL-17A promotes pulmonary inflammation in rats with pulmonary fibrosis induced by bleomycin].
Huang C; Li Y; Fan X; Ma Y; Zhang M; Wang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Apr; 30(4):366-70. PubMed ID: 24721403
[TBL] [Abstract][Full Text] [Related]
9. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
10. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
Liu HZ; Yang HZ; Mi S; Cui B; Hua F; Hu ZW
Yao Xue Xue Bao; 2010 Aug; 45(8):976-86. PubMed ID: 21348427
[TBL] [Abstract][Full Text] [Related]
11. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
Koike A; Hayashi K; Fujimori K
Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
14. Development of a non-infectious rat model of acute exacerbation of idiopathic pulmonary fibrosis.
Chen SS; Yin ZF; Chen T; Qiu H; Wei YR; Du SS; Jin YP; Zhao MM; Wu Q; Weng D; Li HP
J Thorac Dis; 2017 Jan; 9(1):96-105. PubMed ID: 28203411
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
Wilson MS; Madala SK; Ramalingam TR; Gochuico BR; Rosas IO; Cheever AW; Wynn TA
J Exp Med; 2010 Mar; 207(3):535-52. PubMed ID: 20176803
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
18. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
19. Dioscin attenuates Bleomycin-Induced acute lung injury via inhibiting the inflammatory response in mice.
Wu ZL; Wang J
Exp Lung Res; 2019 Oct; 45(8):236-244. PubMed ID: 31452411
[No Abstract] [Full Text] [Related]
20. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
